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Ageing and blood pressure
Hypertension is a major risk factor for cardiovascular 
disease, but it is also very prevalent in the community. 
These two factors combined prompted the World Health 
Organization (WHO) to report that high blood pressure is 
the first cause of death worldwide.1 The prevalence of 
hypertension has been estimated to be approximately one 
in four, and this increases with age to such an extent that 
almost two-thirds of people over the age of 60 years have 
hypertension.2 
The pattern of hypertension also changes with increasing 
age. People above the age of 50 years have an increasing rise 
in systolic blood pressure while the diastolic blood pressure 
tends to remain the same or even start to decrease, so that 
the prevalence of isolated systolic hypertension increases 
with increasing age.  The pulse pressure also increases 
as a result of this pattern of blood pressure change.2 The 
increase of systolic blood pressure is most probably due 
to an increase in stiffening of the large arteries, such as the 
aorta. 
As a result of these changes, there is an increase in the 
prevalence of elevated systolic pressures in people above 
the age of 50 years of age. Since more than 75% of people 
with high blood pressure fall into this  age group, the burden 
of disease is mainly due to systolic blood pressure.3 The 
risk of cardiovascular disease increases progressively with 
increases in blood pressure, both  systolic and diastolic, 
approximately doubling for every 20/10 mmHg increase 
in these  respective blood pressures.4 An increase of 
20 mmHg in systolic blood pressure is associated with a 
more than twofold increase in the death rate, due to stroke 
and  ischaemic  heart disease. 
Elevated systolic blood pressure is  now understood 
conceptually as a more important risk factor for 
cardiovascular disease than diastolic blood pressure.5 The 
Framingham  Heart Study demonstrated that lower systolic 
blood pressure, fewer cigarettes smoked and higher forced 
vital capacity are associated with increased life expectancy, 
with survival to 75 years of age.6
Types of hypertension in the elderly
• Classic systolic/diastolic hypertension: This is a common 
type of hypertension, even in older people.  For example, 
in the STOP-Hypertension trial (n = 1 627 patients), 
the mean age was 75.7 years, the mean systolic blood 
pressure was 195 mmHg, and the mean diastolic 
pressure was 102 mmHg.7 
• Classic isolated systolic hypertension: This type of 
hypertension is common, specifically in older people.  For 
example, in the Syst-Eur trial, (n = 4 695 patients),  the 
mean age was 70.2 years and the mean systolic blood 
pressure was 173.9 mmHg, while the mean diastolic 
blood pressure was 85.5 mmHg.8
• Pseudohypertension: In rare cases, the peripheral arteries 
of elderly patients can become so rigid that the blood 
pressure cuff measurement leads to an overestimate of 
the true blood pressure. Overtreatment in these cases 
will lead to postural hypotension.
Differential diagnosis of isolated 
hypertension
Isolated systolic hypertension is diagnosed when the 
systolic blood pressure is measured as 140 mmHg or more, 
and the diastolic blood pressure is 90 mmHg or less. An 
identical blood pressure pattern can, however, be caused by 
aortic insufficiency and a number of conditions of increased 
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cardiac output, such as severe anaemia, hyperthyroidism, 
Paget’s disease and arteriovenous fistula. These conditions 
should be excluded before diagnosing isolated systolic 
hypertension.
Management of hypertension in the 
elderly
The general therapy and goals of treatment of hypertension 
is the same for the elderly as for all other people with 
hypertension. The goal of treatment is to reduce blood 
pressure to below 140/90 mmHg, and to below 130/80 
mmHg for patients with diabetes and chronic renal disease.
Lifestyle changes
Lifestyle modifications recommended in the elderly, 
including those with isolated systolic hypertension, are the 
same as for all other patients and types of hypertension. 
These lifestyle changes include salt restriction, weight 
reduction, a diet rich in fruit and vegetables but low in 
saturated fat , moderate alcohol intake (two drinks per day 
for  men and one for women), and exercise.9
Drug treatment
The major benefits of pharmacological treatment are related 
to the reduction of blood pressure, rather than to any 
specific type of drug or drug action. Five major classes of 
drugs, each shown in clinical trials to reduce events and 
mortality, are generally used, i.e. diuretics, angiotensin-
converting enzyme inhibitors (ACE inhibitors), angiotensin-
receptor blockers (ARBs), calcium-channel blockers, and 
beta blockers. All of these drugs have been tested in the 
elderly, and proven to be of benefit.9
Compelling indications for certain antihypertensive drugs 
are the same as for all other types of patients, e.g. an ACE 
inhibitor or beta blocker should be prescribed for survivors 
of myocardial infarction with concomitant hypertension.
The use of beta blockers as first-line monotherapy has 
also been questioned, as it has been when prescribed as 
monotherapy for all other types of hypertension. Adding a 
beta blocker to other antihypertensive drugs, either for a 
compelling indication or as a combination  to control blood 
pressure to goal, is still acceptable.
Areas of uncertainty
• How low should the pressure go?9 
 The reduction of diastolic blood pressure in isolated 
systolic hypertension is not difficult to achieve. What is 
not adequately known is whether harm can be caused 
by lowering diastolic blood pressure excessively, and at 
what level of diastolic blood pressure this harm will occur. 
Diastolic pressure below 60 mmHg (i.e. the pressure 
needed to perfuse the myocardium) is considered to 
be possibly harmful, and could lead to an increase in 
cardiovascular events, the so-called J-curve effect. More 
research is needed in this area.
• Treatment of the very old:
 Will the very old (> 80 years) also benefit from the treatment 
of hypertension? In the HYVET trial (HYpertension in the 
Very Elderly Trial) (n = 3 845 patients), the participants 
with a mean age of 83.6 years were treated with a diuretic 
(indapamide) to which an ACE inhibitor, perindopril, 
could be added for blood pressure control. The results 
demonstrated that cardiovascular events could be 
significantly reduced after only an average of 1.8 years 
of treatment.10 There is, therefore, benefit, even for the 
very old.
• Effect of treatment on dementia:
 The true effect of antihypertensive therapy on dementia 
is still uncertain. In the Syst-Eur trial, the incidence of 
dementia was approximately 50% lower among the drug-
treated group of patients when compared to those that 
were not treated. In many other trials, no deterioration of 
mental function was noted. Studies are still ongoing.
Blood pressure reduction in people of 
different ages
Is there a difference in the benefit seen in younger people 
and older people? Recently, the Blood Pressure Lowering 
Treatment Trialists’ Collaboration (BPLTTC) published a 
meta-analysis of 31 trials conducted in more than 190 000 
randomised patients.11 This analysis showed that the relative 
risk reduction of cardiovascular events with control of blood 
pressure occurred irrespective of the age of the patient. 
An arbitrary cut-off point of 65 years of age was used to 
distinguish between younger and older patients. As the 
absolute risk in the elderly is higher than in younger patients 
due to age alone, it implies that, if the relative risk reduction 
is the same regardless of age, then older patients will have 
more absolute benefit and smaller numbers needed to treat 
to prevent an event.
Approach to treatment
The British guidelines propose that, in people below 55 
years of age, treatment be initiated with a renin-angiotensin 
system (RAS) blocker, such as an ACE inhibitor or an ARB. 
For those older than 55 years of age, treatment should be 
started with a diuretic or calcium-channel antagonist.12 
If there is a compelling indication for another drug, that 
Review: Antihypertensive treatment in the elderly 
43 Vol 53 No 1S Afr Fam Pract 2011
should be prescribed. For isolated systolic hypertension, 
a thiazide-like diuretic should be started. To control blood 
pressure, a RAS blocker and/or calcium-channel blocker 
can be added.9 This is the recommendation of at least two 
different opinion leaders.
How effective is the treatment?
In a Cochrane review of 15 trials with 24 055 healthy patients 
older than 60 years of age, mortality was significantly 
reduced, from 116 events per 1 000 to 104 events per 
1 000 (hazard ratio 0.90, 95% CI 0.84-0.97). Morbid cardiac 
events were reduced from 149 per 1 000 to 106 per 1 000 
(hazard ratio 0.70, 95% CI 0.68-0.77). In three trials restricted 
to isolated systolic hypertension, the benefits were similar. 
In the very elderly (> 80 years of age), the benefits were 
similar, but there was no reduction in mortality.13
Conclusion
Early and aggressive management of hypertension, to reach 
goal blood pressure, is what is called for, regardless of age.
Treating people of 60 years and older with moderate to 
severe systolic and/or diastolic hypertension, including 
isolated systolic hypertension, reduces cardiovascular 
morbidity and mortality. The decrease in mortality is limited 
to persons 60 to 80 years of age.
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